SEARCH

SEARCH BY CITATION

References

  • 1
    Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998;102(4 Pt 1):558562.
  • 2
    Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(5 Part 2):S147S334.
  • 3
    Passalacqua G, Canonica GW. Sublingual or injection immunotherapy: the final answer? Allergy 2004;59:3738.
  • 4
    Ross RN, Nelson HS, Finegold I. Effectiveness of specific immunotherapy in the treatment of allergic rhinitis: an analysis of randomized, prospective, single- or double-blind, placebo-controlled studies. Clin Ther 2000;22:342350.
  • 5
    Nelson HS. Advances in upper airway diseases and allergen immunotherapy. J Allergy Clin Immunol 2003;111(3 Suppl.):S793S798.
  • 6
    Frew AJ. 25. Immunotherapy of allergic disease. J Allergy Clin Immunol 2003;111(2 Suppl.):S712S719.
  • 7
    Nelson HS. Advances in upper airway diseases and allergen immunotherapy. J Allergy Clin Immunol 2005;115:676684.
  • 8
    Cox LS, Linnemann DL, Nolte H, Weldon D, Finegold I, Nelson HS. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol 2006;117:10211035.
  • 9
    Nelson HS. Advances in upper airway diseases and allergen immunotherapy. J Allergy Clin Immunol 2006;117:10471053.
  • 10
    Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't [editorial] [see comments]. Br Med J 1996;312:7172.
  • 11
    Bousquet J, Van Cauwenberge P. A critical appraisal of ‘evidence-based medicine’ in allergy and asthma. Allergy 2004;59(Suppl. 78):1220.
  • 12
    Wilson DR, Lima MT, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005;60:412.
  • 13
    Marogna M, Spadolini I, Massolo A, Canonica GW, Passalacqua G. Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more. Allergy 2004;59:12051210.
  • 14
    Marogna M, Spadolini I, Massolo A, Canonica GW, Passalacqua G. Clinical, functional, and immunologic effects of sublingual immunotherapy in birch pollinosis: a 3-year randomized controlled study. J Allergy Clin Immunol 2005;115:11841188.
  • 15
    Tonnel AB, Scherpereel A, Douay B, Mellin B, Leprince D, Goldstein N et al. Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy. Allergy 2004;59:491497.
  • 16
    Bufe A, Ziegler-Kirbach E, Stoeckmann E, Heidemann P, Gehlhar K, Holland-Letz T et al. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study. Allergy 2004;59:498504.
  • 17
    Sopo SM, Macchiaiolo M, Zorzi G, Tripodi S. Sublingual immunotherapy in asthma and rhinoconjunctivitis; systematic review of paediatric literature. Arch Dis Child 2004;89:620624.
  • 18
    Pajno GB, Passalacqua G, Vita D, Caminiti L, Parmiani S, Barberio G. Sublingual immunotherapy abrogates seasonal bronchial hyperresponsiveness in children with Parietaria-induced respiratory allergy: a randomized controlled trial dagger. Allergy 2004;59:883887.
  • 19
    Smith H, White P, Annila I, Poole J, Andre C, Frew A. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis. J Allergy Clin Immunol 2004;114:831837.
  • 20
    Rolinck-Werninghaus C, Wolf H, Liebke C, Baars JC, Lange J, Kopp MV et al. A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen. Allergy 2004;59:12851293.
  • 21
    Bowen T, Greenbaum J, Charbonneau Y, Hebert J, Filderman R, Sussman G et al. Canadian trial of sublingual swallow immunotherapy for ragweed rhinoconjunctivitis. Ann Allergy Asthma Immunol 2004;93:425430.
  • 22
    Marcucci F, Sensi L, Di Cara G, Incorvaia C, Frati F. Dose dependence of immunological response to sublingual immunotherapy. Allergy 2005;60:952956.
  • 23
    Dahl R, Kapp A, Colombo G, De Monchy JG, Rak S, Emminger W et al. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006;118:434440.
  • 24
    Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006;117:802809.
  • 25
    Passalacqua G, Pasquali M, Ariano R, Lombardi C, Giardini A, Baiardini I et al. Randomized double-blind controlled study with sublingual carbamylated allergoid immunotherapy in mild rhinitis due to mites. Allergy 2006;61:849854.
  • 26
    Olaguibel JM, Alvarez Puebla MJ. Efficacy of sublingual allergen vaccination for respiratory allergy in children. Conclusions from one meta-analysis. J Investig Allergol Clin Immunol 2005;15:916.
  • 27
    Moingeon P. Sublingual immunotherapy: from biological extracts to recombinant allergens. Allergy 2006;61(Suppl. 81):1519.
  • 28
    Akdis CA, Barlan IB, Bahceciler N, Akdis M. Immunological mechanisms of sublingual immunotherapy. Allergy 2006;61(Suppl. 81):1114.
  • 29
    Bousquet J. Sublingual immunotherapy: from proven prevention to putative rapid relief of allergic symptoms. Allergy 2005;60:13.
  • 30
    Bousquet J. Sublingual immunotherapy: validated!. Allergy 2006;61(Suppl. 81): 56.
  • 31
    Bieber T. Allergen-specific sublingual immunotherapy: less mystic, more scientific. Allergy 2006;61:149150.
  • 32
    Canonica GW, Passalacqua G. Sublingual immunotherapy in the treatment of adult allergic rhinitis patients. Allergy 2006;61(Suppl. 81): 2023.
  • 33
    Calamita Z, Saconato H, Pela A, Atallah A. Efficacy of sublingual immunotherapy in asthma: systematic review of randomized clinical trials. Allergy 2006;61:11621172.
  • 34
    Valovirta E, Jacobsen L, Liorring C, Koivikko A, Savolainen J. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children. Allergy 2006;61:11771183.
  • 35
    Andre C, Vatrinet C, Galvain S, Carat F, Sicard H. Safety of sublingual-swallow immunotherapy in children and adults. Int Arch Allergy Immunol 2000;121:229234.
  • 36
    Canonica GW, Compalati E, Fumagalli F, Passalacqua G. Sublingual and oral immunotherapy. Immunol Allergy Clin North Am 2004;24:685704, vii.
  • 37
    Baena-Cagnani CE, Passalacqua G, Baena-Cagnani RC, Croce VH, Canonica WG. Sublingual immunotherapy in pediatric patients: beyond clinical efficacy. Curr Opin Allergy Clin Immunol 2005;5:173177.
  • 38
    Agostinis F, Tellarini L, Canonica GW, Falagiani P, Passalacqua G. Safety of sublingual immunotherapy with a monomeric allergoid in very young children. Allergy 2005;60:133.
  • 39
    Kleine-Tebbe J, Ribel M, Herold DA. Safety of a SQ-standardised grass allergen tablet for sublingual immunotherapy: a randomized, placebo-controlled trial. Allergy 2006;61:181184.
  • 40
    Larsen T, Poulsen L, Melac M, Combescure A, André C, Malling H. Safety and tolerability of grass pollen tablets in sublingual immunotherapy (SLIT. A phase-1 study). Allergy 2006;61:11731176.
  • 41
    Antico A, Pagani M, Crema A. Anaphylaxis by latex sublingual immunotherapy. Allergy 2006;61:12361237.
  • 42
    Dunsky E, Goldstein M, Dvorin D, Belacanech G. Anaphylaxis to sublingual immunotherapy. Allergy 2006;61:1235.
  • 43
    Frew AJ. Immunotherapy: how safe is safe? Clin Exp Allergy 2006;36:251253.
  • 44
    Frew AJ, Powell RJ, Corrigan CJ, Durham SR. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006;117:319325.
  • 45
    Jutel M, Jaeger L, Suck R, Meyer H, Fiebig H, Cromwell O. Allergen-specific immunotherapy with recombinant grass pollen allergens. J Allergy Clin Immunol 2005;116:608613.
  • 46
    Savolainen J, Jacobsen L, Valovirta E. Sublingual immunotherapy in children modulates allergen induced in vitro expression of cytokine mRNA in PBMC. Allergy 2006;61:11841190.
  • 47
    Khinchi MS, Poulsen LK, Carat F, Andre C, Hansen AB, Malling HJ. Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study. Allergy 2004;59:4553.
  • 48
    Malling HJ. Comparison of the clinical efficacy and safety of subcutaneous and sublingual immunotherapy: methodological approaches and experimental results. Curr Opin Allergy Clin Immunol 2004;4:539542.
  • 49
    Bagnasco M, Altrinetti V, Pesce G, Caputo M, Mistrello G, Falagiani P et al. Pharmacokinetics of Der p 2 allergen and derived monomeric allergoid in allergic volunteers. Int Arch Allergy Immunol 2005;138:197202.
  • 50
    Lombardi C, Gani F, Landi M, Falagiani P, Bruno M, Canonica GW et al. Quantitative assessment of the adherence to sublingual immunotherapy. J Allergy Clin Immunol 2004;113:12191220.
  • 51
    Alvarez-Cuesta E, Bousquet J, Canonica G, Durham S, Malling H, Valovirta E. Standards for practical allergen-specific immunotherapy. Allergy 2006;(in press).
  • 52
    Allergen immunotherapy: a practice parameter. American Academy of Allergy, Asthma and Immunology. American College of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 2003;90(1 Suppl. 1):140.
  • 53
    Ortolani C, Agostinis F, Amoroso S, Ariano R, Barbato A, Bassi M et al. Practice parameters for sublingual immunotherapy. Monaldi Arch Chest Dis 2006;65:4446.
  • 54
    Sawyer RT, Gergen PJ, Minnicozzi M, Plaut M, Dong G, Schwaninger JM et al. The future of immunotherapy. Report of a National Institute of Allergy and Infectious Diseases (NIAID), Division of Allergy, Immunology and Transplantation (DAIT) Workshop. Allergy 2006;61:11591161.